Table 3.

Responses to treatment questions.

	2010		2015
	N	%a	N	%a
1. How many cycles before you operate?
Standard 3 cycles	173	53.6	128	53.8
Standard 4 cycles	21	6.5	7	2.9
Variable; depends on response	135	41.8	101	42.5
6 cycles or more	5	1.5	2	0.8
2. After NACT with a complete response, you:
LSC exploration, cytoreduction only if gross disease	12	3.8	11	4.7
Ex-lap, cytoreduction if gross residual	26	8.2	9	3.8
LSC exploration, TLH/BSO even in absence of gross diseaseb	66	20.8	92	39.2
Ex lap with TAH/BSO even in absence of gross diseaseb	225	70.8	111	47.2
Not undergo surgical exploration	5	1.6	1	0.4
Other	24	7.5	11	4.7
3. After NACT with gross residual on ID, you:
If optimally cytoreduced place a port and treat with at least 2 IP cycles	136	42.2	98	42.1
If optimally cytoreduced continue IV chemo	139	43.2	75	32.2
Switch IV treatment to _____	16	5	2	0.9
Treat with IP regardless of cytoreductive result	1	0.3	4	1.7
Treat with more IV regardless of cytoreductive result	59	18.3	45	19.3
4. After NACT with microscopic disease on ID, you:
At least 2 cycles of IP	157	48.9	99	42.9
Continue with same type of IV	164	51.5	118	51.1
Switch IV treatment to _____	12	3.7	7	3
Offer no treatment and start disease surveillance	2	0.6	3	1.3

Key

LSC = laparoscopic; TLH = total laparoscopic hysterectomy; BSO = bilateral salpingo-oophorectomy; TAH = total abdominal hysterectomy; IV = intravenous; IP = intra-peritoneal.

^aPercentages are based on the number of participants responding to each question, some participants marked multiple answers.

^bdenotes statistically significant difference between years p < 0.0001 by two-sample t-test.